Organovo implements 1-for-12 reverse stock split to regain Nasdaq minimum bid price compliance

VivoSim Labs, INC.

Reverse stock split at ratio 1-for-12, effective March 20, 2025, to combine every 12 shares into 1.
Trading on Nasdaq Capital Market on split-adjusted basis begins March 21, 2025 under ticker ONVO.
No fractional shares issued; cash paid in lieu based on March 19 closing price of common stock.
Board approved reverse split ratio on March 6, 2025 after shareholder authorization granted November 20, 2024.
Reverse split intended to cure Nasdaq minimum bid price deficiency for continued listing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.